ROZLYTREK

Hoffmann-La Roche Limited🇨🇦 Health Canada

Approval Id: bab1d346a133e248
Drug Approval Canada Name: ROZLYTREK
Product Name: ROZLYTREK
Status: Marketed
Status Date: 2020-03-04
Original Market Date: 2020-03-04
Din: 02495015
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EX14 ENTRECTINIB
Atc Name: l 01 ex 14
Aig Number: 0162010002
Company Name: Hoffmann-La Roche Limited
Company Address: 7070 Mississauga Road, Mississauga, Ontario, Canada, L5N 5M8

ENTRECTINIB

200 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

bab1d346a133e248

Type

Standard